Synthesis and cytotoxic activity of different open indolocarbazole alkaloid analogues

Bioorganic and Medicinal Chemistry

Volumn 11, Issue 16, 2003, Pages 3413-3421

  Caballero, Esther ^a   Adeva, Marta ^a   Calderón, Suzanne ^a   Sahagún, Heidi ^a   Tomé, Fernando ^a   Medarde, Manuel ^a   Fernández, José Luis ^b   López Lázaro, Miguel ^c   Ayuso, Maria Jesús ^c  

^a UNIVERSITY OF SALAMANCA   (Spain)

^b Instituto Biomar SA   (Spain)

^c UNIVERSITY OF SEVILLE   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

10 (N PHENYLSULFONYLINDOL 3 YL) 2 METHYL 8 METHOXY 3A,4,10,10A TETRAHYDRO 5H PYRROLO[3,4 B]CARBAZOLE 1,3 DIONE; 4 (N PHENYLSULFONYLINDOL 3 YL) 2 METHYL 9 METHOXY 3A,4,5,10C TETRAHYDRO 6H PYRROLO[3,4 C]CARBAZOLE 1,3 DIONE; 6 FORMYLAMINO 12,13 DIHYDRO 1,11 DIHYDROXY 5H INDOLO[2,3 A]PYRROLO[3,4 C]CARBAZOLE 5,7(6H) DIONE 13 GLUCOSIDE; ALKALOID DERIVATIVE; INDOLOCARBAZOLE; KETONE DERIVATIVE; REBECCAMYCIN; STAUROSPORINE; UNCLASSIFIED DRUG;

ARTICLE; CARBON NUCLEAR MAGNETIC RESONANCE; DIELS ALDER REACTION; DRUG ACTIVITY; DRUG CYTOTOXICITY; DRUG SYNTHESIS; INFRARED SPECTROSCOPY; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROTON NUCLEAR MAGNETIC RESONANCE;

BETULACEAE;

EID: 0037811473     PISSN: 09680896     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0968-0896(03)00308-0     Document Type: Article

References (39)

1. Pindur U., Kim Y.S., Mehrabani F. Curr. Med. Chem. 6:1999;29.
2. Steglich W., Steffan B., Kopanski L., Eckhardt G. Angew. Chem., Int. Ed. Engl. 19:1980;459.
3. Slater M.J., Cockerill S., Baxter R., Bonser R.W., Gohil K., Gowrie C., Robinson J.E., Littler E., Parry N., Randall R., Snowden W. Bioorg. Med. Chem. 7:1999;1067.
4. Nettleton D.E., Doyle T.W., Krishnan B., Matsumoto G.K., Clardy J. Tetrahedron Lett. 26:1985;4011.
5. Omura S., Iwai Y., Hirano A., Nakagawa A., Awaya J., Tsuchiya H., Takahashi Y., Masuma R. J. Antibiot. 30:1977;275.
6. Marminon C., Anizon F., Moreau P., Léonce S., Pierré A., Pfeiffer B., Renard P., Prudhomme M. J. Med. Chem. 45:2002;1330.
7. Marschall M., Stein-Gerlach M., Freitag M., Kupfer R., van der Bogaard M., Stamminger T. J. General Virology. 83:2002;1013.
8. Akinaga S., Sugiyama K., Akiyama T. Anticancer Drug Des. 15:2000;43.
9. (a) Caballero E., Guilhot F., López J.L., Medarde M., Sahagún H., Tomé F. Tetrahedron Lett. 37:1996;6951.
10. (b) Adeva M., Caballero E., García F., Medarde M., Sahagún H., Tomé F. Tetrahedron Lett. 38:1996;6893.
11. (c) Caballero E., Longieras N., Zausa E., Del Rey B., Medarde M., Tomé F. Tetrahedron Lett. 42:2001;7233.
12. (a) Acosta J.C., Caballero E., Grávalos D.G., Medarde M., Sahagún H., Stoodley R.J., Tomé F. Bioorg. Med. Chem. Lett. 7:1997;2955.
13. (b) Caballero E., Medarde M., Pelaez-Lamamie de Clairac R., Sahagún H., Tomé F. Tetrahedron. 54:1998;6111.
14. Adeva M., Buono F., Caballero E., Medarde M., Tomé F. Synlett. 2000;832.
15. (a) Caballero E., García F., Grávalos D.G., Medarde M., Sahagún H., Tomé F. Bioorg. Med. Chem. Lett. 6:1996;2459.
16. (b) Adeva M., Sahagún H., Caballero E., Pelaez-Lamamie de Clairac R., Medarde M., Tomé F. J. Org. Chem. 65:2000;3387.
17. (c) Ref 9c.
18. (a) Shi Q., Chen K., Morris-Natschke S.L., Lee K.-H. Current Pharmaceutical Design. 4:1998;219
19. (b) Sengupta, S. K. Topoisomerase II Inhibitors. Inhibitors of DNA Topoisomerases, In Cancer Chemotherapeutic Agents, Foye W. O., Ed.; ACS: Washington, 1995; pp 205-217.
20. Cory, M. DNA Minor-Groove Binding Compounds as Antitumor-Agents, In Cancer Chemotherapeutic Agents, Foye W. O., Ed.; ACS: Washington, 1995; pp 311-344.
21. Hodgson S.T., Jenkins D.C., Knick V., Rapson E., Watts S.D.M. Bioorg. Med. Chem. Lett. 2:1992;1257.
22. Copp B.R., Ireland C.M., Barrows L.R. J. Org. Chem. 56:1991;4596.
23. Badre A., Boulanger A., Abou-Mansour E., Banaigs B., Combaut G., Francisco C. J. Nat. Prod. 57:1994;528.
24. MacDonald, T. L.; Lehnert, E. K.; Loper, J. T.; Chow, K.; Ross, W. E. In DNA Topoisomerase in Cancer: Potmesil, M.; Kohn, K. W. Eds.: Oxford University Press: New York, 1991; pp 119-214.
25. (a) Bergman, J. In Studies in Natural Products Chemistry, Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, 1988; Vol. 1, pp 3-30
26. (b) Gribble, G. W.; Berthel, S. J. In Studies in Natural Products Chemistry, Atta-ur-Rahman, Ed.; Elsevier: Amsterdam, 1993; Vol. 12, pp 365-409.
27. (c) Ref 1.
28. (d) Merlic C.A., Ying Y., McInnes D.M., Zechman A.L., Miller M.M., Deng Q. Tetrahedron. 57:2001;5199. and references cited therein.
29. (e) Knölker H.-J., Reddy K.R. Chem. Rev. 102:2002;4303.
30. Moody C.J., Rahimtoola K.F. J. Org. Chem. 57:1992;2105.
31. Nomak, R.; Snyder, J. K. 216th ACS National Meeting, ORGN Abstract 543, Boston, 1998.
32. Broka, C. A. European Patent 695755, 1996; Chem. Abstr. 1996, 124, 289516.
33. Kleinschroth, J.; Hartenstein, J.; Schaechtele, C.; Rudolph, C.; Dooley, D. J.; Weinheimer, G. U.S. Patent 4912107, 1990; Chem. Abstr. 1990, 113, 191154.
34. McCort G., Duclos O., Cadilhac C., Guilpain E. Tetrahedron Lett. 40:1999;6211.
35. Ikuina, Y.; Kanai, F.; Shiotsu, Y.; Iida, T.; Yamashita, K.; Saitoh, Y.; Akinaga, S.; Tamaoki, T.; Murakata, C. 217th ACS National Meeting, MEDI Abstract 089, Anaheim, 1999.
36. Steglich W. Pure & Appl. Chem. 61:1989;281.
37. (a) Kleinschroth J., Hartestein J., Rudolph C., Schächtele C. Bioorg. Med. Chem. Lett. 5:1995;55.
38. (b) Facompré M., Baldeyrou B., Bailly C., Anizon F., Marminon C., Prudhomme M., Colson P., Houssier C. Eur. J. Med. Chem. 37:2002;925. and references cited therein.
39. Monks A., Scudeiro D., Skehan P., Shoemaker R., Paull K., Vistica D., Hose C., Langley J., Cronise P., Vaigro-Wolff A., Gray-Goodrich M., Campbell H., Mayo J., Boyd M. J. Natl. Cancer Inst. 83:1991;757.